Revance Therapeutics Inc (RVNC)

3.08 +0.01 (+0.33%) USD  |  NASDAQ  |  Dec 20, 16:00
3.05 -0.03 (-0.97%) After-Hours: 20:00
More

Revance Therapeutics EPS LT Growth Estimates

EPS LT Growth Estimates Chart

View EPS LT Growth Estimates for RVNC.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS LT Growth Estimates Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS LT Growth Estimates Range, Past 5 Years

View EPS LT Growth Estimates Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS LT Growth Estimates Benchmarks

View EPS LT Growth Estimates Benchmarks
Start Trial
Recursion Pharmaceuticals Inc --
Regeneron Pharmaceuticals Inc Upgrade
Ligand Pharmaceuticals Inc Upgrade
MEI Pharma Inc --
Cellectar Biosciences Inc --